Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Monotherapy</td><td align="center">Two-drug regimen</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Piperacillin-tazobactam</td><td align="center">Piperacillin-tazobactam + amikacin</td></tr><tr><td align="left">Imipenem-cilastatin</td><td align="center">Imipenem-cilastatin + amikacin</td></tr><tr><td align="left">Meropenem</td><td align="center">Meropenem + amikacin</td></tr><tr><td align="left">Ceftazidime</td><td align="center">Ceftazidime + amikacin</td></tr><tr><td align="left">Cefepime</td><td align="center">Ceftriaxone + amikacin</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Intravenous antibiotics for empirical therapy of fever in neutropenic patients.

Advances in Hematology

tab3

Table 3

Table 3: Treatment of Febrile Neutropenia and Prophylaxis in Hematologic Malignancies: A Critical Review and Update 